- 619 days ago by Briana Rognlin
- 2 Comments »
- Share a Tip
Anyone who’s been lobbying to legalize marijuana might be excited to know that scientists at a startup biotech company, Medicinal Genomics, have completed the DNA sequence for marijuana (or Cannabis sativa, as it’s called in the labs). But there’s a catch: Their goal isn’t to produce the next best Purple Haze, it’s to eliminate (or at least greatly reduce) its mind-altering elements and produce a strain that’s better-suited to treating pain and aiding treatment of diseases like cancer. More





